EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy

Jolijn R van Leeuwen iD, Luca Quartuccio iD, Juliana Bordignon Draibe, Iva Gunnarson, Ben Sprangers, Y K Onno Teng iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s341842 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Jolijn R van Leeuwen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Expertise for Lupus-, Vasculitis- and Complement-Mediated Systemic Diseases (Luvacs), Department of Internal Medicine - Nephrology Section,…. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Drug Development, Drug Design. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisDrug DevelopmentDrug DesignHumansGlucocorticoidsAnimalsAniline CompoundsNipecotic Acids

Stichwörter der Autor:innen

ANCAC5a inhibitionantineutrophil cytoplasmic antibodycomplementglucocorticoid toxicitypauci-immune glomerulonephritis

Substanzen

avacopanGlucocorticoidsAniline CompoundsNipecotic Acids

Autor:innen und Institutionen

  • Center of Expertise for Lupus-, Vasculitis- and Complement-Mediated Systemic Diseases (Luvacs), Department of Internal Medicine - Nephrology Section, Leiden University Medical Center, Leiden, the Netherlands.
  • Division of Rheumatology, Department of Medicine, University of Udine, Udine, Italy.
  • Department of Nephrology, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.
  • Division of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital, Stockholm, Sweden.
  • Department of Nephrology, Ziekenhuis Oost Limburg Genk, Genk, Belgium.

ORCID-Profile: Jolijn R van Leeuwen, Luca Quartuccio, Y K Onno Teng

Zitieren

APA

van Leeuwen, J. R., Quartuccio, L., Draibe, J. B., Gunnarson, I., Sprangers, B., & Teng, Y. K. O. (2025). Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s341842

Vancouver

van Leeuwen JR, Quartuccio L, Draibe JB, Gunnarson I, Sprangers B, Teng YKO. Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s341842

BibTeX
@article{vanLeeuwen2025,
  author = {van Leeuwen, Jolijn R and Quartuccio, Luca and Draibe, Juliana Bordignon and Gunnarson, Iva and Sprangers, Ben and Teng, Y K Onno},
  title = {Evaluating Avacopan in the Treatment of ANCA-Associated Vasculitis: Design, Development and Positioning of Therapy},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s341842}
}
Kostenlos starten →